Searchable abstracts of presentations at key conferences in endocrinology

ea0035p710 | Neuroendocrinology | ECE2014

Meal-induced plasma ghrelin suppression in different phases of anorexia nervosa

Polli Nicoletta , Giunta Francesca , Cesari Miriam , Zappulli Daniela , Scacchi Massimo , Persani Luca

Introduction: The ghrelin suppressive effect of food is well established in normal subjects, whereas the effectiveness of meals in decreasing plasma ghrelin in patients with anorexia nervosa (AN) is still debated. Based on the above, we elected to study the ghrelin dynamics after food or placebo in a group of anorectic girls at the moment of diagnosis and after weight recuperation.Study design: Nine anorectic women (age 14–32 years) were studied. Bo...

ea0035p807 | Paediatric endocrinology | ECE2014

Usefulness of ACTH stimulation in the differential diagnosis of precocious pubarche

Santos Maria Joana , Amaral Daniela , Limbert Catarina , Pina Rosa , Lopes Lurdes

Introduction: Nonclassical congenital adrenal hyperplasia (NCCAH) is caused by reduced 21-hydroxylase activity, leading to excessive adrenal androgens and premature pubarche (PP); idiopathic PP (IPP) is its main differential diagnosis. The gold standard for the differential diagnosis is ACTH stimulation test (ST); this test also estimates the adrenal cortisol reserve in NCCAH patients.Objectives: To compare the clinical characteristics and baseline hormo...

ea0035p944 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Weight and metabolic profile evolution in patients with treated prolatinomas

Guelho Daniela , Gomes Leonor , Paiva Isabel , Saraiva Joana , Moreno Carolina , Cardoso Luis , Vicente Nuno , Carrilho Francisco

Introduction: The metabolic consequences of hyperprolactinemia and the repercussions of its treatment with dopaminergic agonists are not yet fully understood. This study aims to evaluate the metabolic profile of patients with prolactinomas (prevalence of diabetes mellitus, dyslipidaemia and obesity) and identify the potential variations after treatment with bromocriptine.Methods: Retrospective study of patients followed between 1962 and 2013. Included 17...

ea0035p969 | Thyroid (non-cancer) | ECE2014

Evolution of thyroid function in Hashimoto's thyroiditis and related disorders–January 2014

Poiana Catalina , Carsote Mara , Staicu Cristina Daniela , Clodeanu Alexandrina , Peretianu Dan

Aim: Analyzing the evolution of thyroid function in thyroiditis and related disease between 1–20 years.Material and method: i). Diagnostic: Hashimoto thyroiditis (HT): 1. antithyroperoxydase antibodies (ATPO), cut-off 34 ui/ml. 2. if ATPO=normal, thyroiditis was considered if high antithyroglobuline antibodies (T-ATG); 3. idiopathic mixedema (IM): hypothyroidism with no ATPO, no A...

ea0035p970 | Thyroid (non-cancer) | ECE2014

Immune associations in chronic thyroiditis – January 2014

Carsote Mara , Poiana Catalina , Staicu Cristina Daniela , Clodeanu Alexandrina , Peretianu Dan

Material and method: i). Patients: A. ‘Classical’ Hashimoto thyroiditis (hyper-ATPO-emia, HT) =1293, B. thyroiditis with isolated hyper-ATG-emia, with normal ATPO (T-ATG) =92, C. thyroiditis ‘sero-negative’ (normal ATPO and ATG, pathology diagnosis) =11, D. idiopathic myxedema (hypothyroidism, no A,B,C) =86; E. control=1219. 2. Statistical analysis: X2 test, z test.Results:...

ea0035p971 | Thyroid (non-cancer) | ECE2014

Relationships between antithyroperoxydase antibody and antithyroglobulin antibody levels with thyroid function in chronic thyroiditis – January 2014

Carsote Mara , Poiana Catalina , Daniela S Cristina , Clodeanu Alexandrina , Peretianu Dan

Aim and Objectives: Is Hashimoto thyroiditis (HT) different from thyroiditis with only antithyroglobulin antibodies (T-ATG)?Material and method: i). Diagnosis: ATPO >34 ui/ml = HT; ATPO normal with high ATG (>34 ui/ml) =T-ATG. ii). Thyroid function: TSH. iii). Patients: HT=1293, T-ATG=92. iv). Statistical analysis: Student tα, linear correlation tests....

ea0070aep71 | Adrenal and Cardiovascular Endocrinology | ECE2020

Cardiovascular risk and metabolic profile in adult patients with congenital adrenal hyperplasia

Barbot Mattia , Ceccato Filippo , Patelli Ilaria , Regazzo Daniela , Lizzul Laura , Scaroni Carla

Background: Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is characterized by impaired cortisol synthesis, requiring life-long glucocorticoid (GC) replacement therapy. Given the detrimental systemic effects of GCs in the long term, the aim of our study was to assess whether CAH patients have increased metabolic and cardiovascular alterations compared with age-matched controls.Materials and methods: For this cross-sectional...

ea0070aep202 | Bone and Calcium | ECE2020

Body composition and adipokines influence upon bone mineral density and bone metabolism in renal transplant receivers

Matei Anca , Bilha Stefana , Constantinescu Daniela , Cianga Petru , Covic Adrian , Branisteanu Dumitru

Introduction: Renal transplant receivers (RTR) have a higher risk for osteoporosis, obesity and sarcopenia, which all seem to be interrelated. FGF23 and adipokine disorders, often recognized in RTR, might be involved in the fat-muscle-bone crosstalk. The current study aims to evaluate the influence of body compartiments and adipokines on bone mass in RTR.Methods: Thiscross-sectional study investigates the predictive role of body composition, adipokines (...

ea0070aep268 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Association of the APOEgene polymorphism with diabetic nephropathy

Hasan Taner , Josifovska Slavica , Trajkovska Ivana , Doneva Daniela , Nedeska Natasha , Volkanovska Ilijevska Cvetanka

The protein isoformes that are products of the Apolipoprotein E (APOB) gene polymorphism have partially altered biological activity and that may lead to greater susceptibility of the patientsto microvascular complications including Diabetic nephropathy (DN)in patients with the Type 2 diabetes mellitus (T2DM). The aim of this study was to evaluate the association between the allele ε2, ε3, and ε4 of the APOE gene, as well as their combination, w...

ea0070aep549 | General Endocrinology | ECE2020

True hyponatremia – An unusual side effect of IV Immunoglobulins

Daniela Aflorei Elena , Jane Bracken Amanda , Stanciu Roxana , Tanase Dan , Kong Ngai

Background: Guillain-Barré syndrome is a rare but very serious autoimmune disorder and it’s caused by the immune led demyelination of the peripheral nervous system. The symptoms are mainly weakness and numbness, but can also consist in severe respiratory failure due to paralysis. The treatment consist in administration of intravenous immunoglobulins (IVIGs) which shorten the duration of disease.Case presentation: A 67 year-old m...